{"ticker": {"uuid": "626aa4e8-767a-4a19-b54c-f85de1cdf783", "symbol": "MOLN", "name": "Molecular Partners AG", "exchange": "EBS", "country": "CH", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Molecular Partners AG (MOLN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFA3SjNpRmFhWi1rUThMWHg5ZVpQNkR2ZTJweUR6SDFJa1NwMzlhWDNERnQxY2M4cDN6dno0SHo1bHJwa2lIdnpRYTV6OTV4SEY3LWFWSFFWbTJES1ZfOHhZMnNVX1lneHFzYjdsM3VR?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T09:54:27+00:00", "published_display": "18 Jun 2026 09:54", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners AG (MOLN) Institutional Confidence", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE15WVFHcTZDaFEyRHFTYWtqY0NIdm5BV2U5eVF5ME1kZzIwZmNfNE93NFNBS1R3amFxS0RibWlacThJbVZTZzRvRXRoNHhOMzRudFZPR2NtdllaWUpOVWFNMnRCbnFCQ21LczZmYTBOT2I?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners AG (MOLN) Valuation: PE, PB & Fair Value Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE9lMEhXY3l5M1ZjU1VvSXE2NVotZi1ZQlhjenZpVkdlVU02RlVla09VMnpTdXVfUmpDRXFGVzVGUFdFSFR1SW1DTjVOR0JnRjJ5WHcwVGR4N3VyUHJjM3hhdEVWOHV5c3FPQW1VWjRWWGlqd1BNWkh3bXdPNA?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners AG (MOLN) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTFByV1Vhc0toVnktbUFpRnNTWkNTV1piZlpIV2VVb2VHUHFnY0piR1RKcldlVVdrMUQyR1gxNkFoRll0UHQ1bE9tU1FwcV9zRXV6M2hkNkVsNTJzNHVuNGxHMmdLN25RTUZTclhHVnd1Z3FYa0duVVE4?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners AG (MOLN) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE5KMERXTHZFckhzc1BMTTZ4NV9UVlJHaUZRejM4UDNHQVVGZmg5VWppdklCWlMzUTJiOER0NmN6U3Q0UjVOSlN0NDhhd0R1dU0tYW1uazY1SGVNUW80OThDMi0xWnlGejhiU3R4YWtJQWtpcEJ6TGdWVg?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T06:11:16+00:00", "published_display": "18 Jun 2026 06:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners AG (MOLN) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE01eFhxeVg2Nk44M3VTVnJKeFRSa0RzdE9KbWFOc1pJZWhEd0liZjBQaFdOUmdPX0gxQUliYTBIQlI3MWdDZ0huU1R4dDktMHZyYmhEcnE0UUZaRGNvalJlQTJQQjBPU09QZkVZUDg1REU?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T01:06:58+00:00", "published_display": "18 Jun 2026 01:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners AG (MOLN) Financial Health: Profitability & Balance Sheet Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE1WT2tYaXhtYlZ6c25FbmlkbVBja19mUlRrZE9ZV1dUS0pXSVloYnlJeDk5aFlRSWZWSVN6OWpvWHZTdVVZbm85UHo3Nm83azJFRlhuVk9fRjZXOTVKSG92QXR6MXBfRkM4a2J4WkVfY1BLZjhHSVRCUGl3?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T18:48:05+00:00", "published_display": "17 Jun 2026 18:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners AG (MOLN) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTFB1dEFQQ3pXZG12dnZuUUNBclhDcWpHTVVGUGpGSkoxaVR6NDRDbFZycktFX1NSNHNzd1FyellPa2FvTTRva051SUNZemtHclhOLVpnbTF6MVRrTWZDRmdvXy1wNC1iX0EwV2IxRjczZWI?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T10:09:02+00:00", "published_display": "17 Jun 2026 10:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners AG (MOLN) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE5RUjNDRUphYnhJOG9HSXFDYVJYRVJqeEVEamtmU19pd3pvOXFZNjV2SDQxZ1R4X1dXNFhDYjhYbHhCNC1iTTRWUEhmWHR5YWNodm9Ick9fZmhvVFhQaFlfeVN4cUxmMXVvWWd6TXgyZw?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T08:57:46+00:00", "published_display": "17 Jun 2026 08:57", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners (MOLN) showcases MP0712 Phase 1/2a data plans at ASCO and SNMMI 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPcmVTb2ZFS1RramxqVE10UWVqX1ZSSVk4eTl3ZVJsNnN4SDBxNno1MzZCeGUtdFFTQVFBTjF2UEJMRWpLRTdRYURxeE04eVdIc3BUMWxwNy1CVEEwcE1wS1pwV1ZoVHVlNmNwM19YUkVha2todjU5VzQ4Z3cwVzZlb3FEejcyampzSEtKODk3SkpjdHFSdkZUdmxjSTRJaEhoUHZnUVRTb1pmY0VXamVWWU1IdVdQd25G?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners Stock Pops Into Holiday Pause as Traders Eye Cancer-Drug Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOSnA3R0FVby02OXBYRnVOTG41STNEQzk0ME14VGMyUFhWVEJDWDhucXRIem5Kd0hwYXRVR01jeDBGMG9xdFNpeFE4NU1sNWtpVVF6NE9ybXdrRTJGOXpDZDJLVXVIVEFEdkNEZGU5WnJSbkRuZGtTa0FYY21hbV9YR29hdXZBUFVWZDgyZ0hlQVZ5NjEybGx4S3d5dWZQOEV4dEhUMjBCZEcwUQ?oc=5", "source_name": "Bez Kabli", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners to cut workforce by a quarter", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNVTF5RFp0MWgwaERURXNQR0MwY01fYmh6Nng1S2pGc0NuTHRkbkdfRTNaUDZxMWNNdXAyYjZHa3VFckNZakJFNFB1R3lrNHhqRnkwaWdpYnA1bkt4ekx4UGRQN3RKR2dWbE8xSmYwbmlFTk9sU3F5QUE2VDhCNUpvalJGalNWNFpPeFFEdkd1WW03cmdfaHhNQ3lVNms4Z24tS05NUmFNSDZyeTdxTkEyeEozb2FXQQ?oc=5", "source_name": "Reuters", "published_at": "2025-06-09T07:00:00+00:00", "published_display": "09 Jun 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners AG Announces Key Developments in Radio-DARPin Programs and Expansion of Partnership with Orano Med", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxOTy05dkd0QlAyNndxY2tOcjVpOG9GellJYjgyaldHTi1pcjBmOUtOTGlYYkM2TzdkN2xCMFluUE1FaEdaWWVXV21aMFQyTmZ1SU9KSldRZFpUUzNZejViQldkdDJrcV9JSW1oMjFjTVdETG51bF9lLVpESUJ2TS1WNzZLcXFVME9oR0ZYQWppRHRZeDFsODBrUzhjR1ZrME9rMjY2MkxSblBvWWJJdkZ2eWlhYi12UWxYcmJjTGcxcGtCM2FuYkkxb2ZNZTNLT3g1YWtJVFdmVEVCNGlpNHVhRUs5bmQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-01-12T08:00:00+00:00", "published_display": "12 Jan 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners (MOLN) Earnings Date and Reports 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE1LT2dKVVZDaVBmYmJIdngwZElFSWFFbkRqQU03Vmpxd3ZfcmhjcF91SEpwRk54eGpHU2IzNm5HN3RKV0x5VmZwTlJScmNzVkhxLWVyVms4NDhhMzB4bUdFUUVPOFdYdw?oc=5", "source_name": "MarketBeat", "published_at": "2021-06-17T00:30:14+00:00", "published_display": "17 Jun 2021 00:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Molecular Partners AG (MOLN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFA3SjNpRmFhWi1rUThMWHg5ZVpQNkR2ZTJweUR6SDFJa1NwMzlhWDNERnQxY2M4cDN6dno0SHo1bHJwa2lIdnpRYTV6OTV4SEY3LWFWSFFWbTJES1ZfOHhZMnNVX1lneHFzYjdsM3VR?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T09:54:27+00:00", "published_display": "18 Jun 2026 09:54", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners AG (MOLN) Institutional Confidence", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE15WVFHcTZDaFEyRHFTYWtqY0NIdm5BV2U5eVF5ME1kZzIwZmNfNE93NFNBS1R3amFxS0RibWlacThJbVZTZzRvRXRoNHhOMzRudFZPR2NtdllaWUpOVWFNMnRCbnFCQ21LczZmYTBOT2I?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners AG (MOLN) Valuation: PE, PB & Fair Value Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE9lMEhXY3l5M1ZjU1VvSXE2NVotZi1ZQlhjenZpVkdlVU02RlVla09VMnpTdXVfUmpDRXFGVzVGUFdFSFR1SW1DTjVOR0JnRjJ5WHcwVGR4N3VyUHJjM3hhdEVWOHV5c3FPQW1VWjRWWGlqd1BNWkh3bXdPNA?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners AG (MOLN) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTFByV1Vhc0toVnktbUFpRnNTWkNTV1piZlpIV2VVb2VHUHFnY0piR1RKcldlVVdrMUQyR1gxNkFoRll0UHQ1bE9tU1FwcV9zRXV6M2hkNkVsNTJzNHVuNGxHMmdLN25RTUZTclhHVnd1Z3FYa0duVVE4?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners AG (MOLN) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE5KMERXTHZFckhzc1BMTTZ4NV9UVlJHaUZRejM4UDNHQVVGZmg5VWppdklCWlMzUTJiOER0NmN6U3Q0UjVOSlN0NDhhd0R1dU0tYW1uazY1SGVNUW80OThDMi0xWnlGejhiU3R4YWtJQWtpcEJ6TGdWVg?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T06:11:16+00:00", "published_display": "18 Jun 2026 06:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners AG (MOLN) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE01eFhxeVg2Nk44M3VTVnJKeFRSa0RzdE9KbWFOc1pJZWhEd0liZjBQaFdOUmdPX0gxQUliYTBIQlI3MWdDZ0huU1R4dDktMHZyYmhEcnE0UUZaRGNvalJlQTJQQjBPU09QZkVZUDg1REU?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T01:06:58+00:00", "published_display": "18 Jun 2026 01:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners AG (MOLN) Financial Health: Profitability & Balance Sheet Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE1WT2tYaXhtYlZ6c25FbmlkbVBja19mUlRrZE9ZV1dUS0pXSVloYnlJeDk5aFlRSWZWSVN6OWpvWHZTdVVZbm85UHo3Nm83azJFRlhuVk9fRjZXOTVKSG92QXR6MXBfRkM4a2J4WkVfY1BLZjhHSVRCUGl3?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T18:48:05+00:00", "published_display": "17 Jun 2026 18:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners AG (MOLN) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTFB1dEFQQ3pXZG12dnZuUUNBclhDcWpHTVVGUGpGSkoxaVR6NDRDbFZycktFX1NSNHNzd1FyellPa2FvTTRva051SUNZemtHclhOLVpnbTF6MVRrTWZDRmdvXy1wNC1iX0EwV2IxRjczZWI?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T10:09:02+00:00", "published_display": "17 Jun 2026 10:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners AG (MOLN) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE5RUjNDRUphYnhJOG9HSXFDYVJYRVJqeEVEamtmU19pd3pvOXFZNjV2SDQxZ1R4X1dXNFhDYjhYbHhCNC1iTTRWUEhmWHR5YWNodm9Ick9fZmhvVFhQaFlfeVN4cUxmMXVvWWd6TXgyZw?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T08:57:46+00:00", "published_display": "17 Jun 2026 08:57", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners (MOLN) showcases MP0712 Phase 1/2a data plans at ASCO and SNMMI 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPcmVTb2ZFS1RramxqVE10UWVqX1ZSSVk4eTl3ZVJsNnN4SDBxNno1MzZCeGUtdFFTQVFBTjF2UEJMRWpLRTdRYURxeE04eVdIc3BUMWxwNy1CVEEwcE1wS1pwV1ZoVHVlNmNwM19YUkVha2todjU5VzQ4Z3cwVzZlb3FEejcyampzSEtKODk3SkpjdHFSdkZUdmxjSTRJaEhoUHZnUVRTb1pmY0VXamVWWU1IdVdQd25G?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners Stock Pops Into Holiday Pause as Traders Eye Cancer-Drug Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOSnA3R0FVby02OXBYRnVOTG41STNEQzk0ME14VGMyUFhWVEJDWDhucXRIem5Kd0hwYXRVR01jeDBGMG9xdFNpeFE4NU1sNWtpVVF6NE9ybXdrRTJGOXpDZDJLVXVIVEFEdkNEZGU5WnJSbkRuZGtTa0FYY21hbV9YR29hdXZBUFVWZDgyZ0hlQVZ5NjEybGx4S3d5dWZQOEV4dEhUMjBCZEcwUQ?oc=5", "source_name": "Bez Kabli", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners to cut workforce by a quarter", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNVTF5RFp0MWgwaERURXNQR0MwY01fYmh6Nng1S2pGc0NuTHRkbkdfRTNaUDZxMWNNdXAyYjZHa3VFckNZakJFNFB1R3lrNHhqRnkwaWdpYnA1bkt4ekx4UGRQN3RKR2dWbE8xSmYwbmlFTk9sU3F5QUE2VDhCNUpvalJGalNWNFpPeFFEdkd1WW03cmdfaHhNQ3lVNms4Z24tS05NUmFNSDZyeTdxTkEyeEozb2FXQQ?oc=5", "source_name": "Reuters", "published_at": "2025-06-09T07:00:00+00:00", "published_display": "09 Jun 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners AG Announces Key Developments in Radio-DARPin Programs and Expansion of Partnership with Orano Med", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxOTy05dkd0QlAyNndxY2tOcjVpOG9GellJYjgyaldHTi1pcjBmOUtOTGlYYkM2TzdkN2xCMFluUE1FaEdaWWVXV21aMFQyTmZ1SU9KSldRZFpUUzNZejViQldkdDJrcV9JSW1oMjFjTVdETG51bF9lLVpESUJ2TS1WNzZLcXFVME9oR0ZYQWppRHRZeDFsODBrUzhjR1ZrME9rMjY2MkxSblBvWWJJdkZ2eWlhYi12UWxYcmJjTGcxcGtCM2FuYkkxb2ZNZTNLT3g1YWtJVFdmVEVCNGlpNHVhRUs5bmQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-01-12T08:00:00+00:00", "published_display": "12 Jan 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molecular Partners (MOLN) Earnings Date and Reports 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE1LT2dKVVZDaVBmYmJIdngwZElFSWFFbkRqQU03Vmpxd3ZfcmhjcF91SEpwRk54eGpHU2IzNm5HN3RKV0x5VmZwTlJScmNzVkhxLWVyVms4NDhhMzB4bUdFUUVPOFdYdw?oc=5", "source_name": "MarketBeat", "published_at": "2021-06-17T00:30:14+00:00", "published_display": "17 Jun 2021 00:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 63, "total_relevant": 14, "sentiment_summary": {"positive": 3, "negative": 2, "neutral": 9, "score": 48, "total": 14, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 4.95, "count": 9}, {"event": "earnings", "label": "Earnings", "weight": 2.55, "count": 4}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 3, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 3.09, "latest_week": "2026-06-19", "one_week_move": 2.0, "four_week_move": -1.9, "twelve_week_move": -4.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.20747, "market_dynamics_buy_signal": false, "relative_strength": -9.592689, "fair_value_gap": -21.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 39.2665, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.0% over one week, -1.9% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingKey", "count": 9}, {"label": "Stock Titan", "count": 1}, {"label": "Bez Kabli", "count": 1}, {"label": "Reuters", "count": 1}, {"label": "Quiver Quantitative", "count": 1}, {"label": "MarketBeat", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 14}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 9}, {"label": "Earnings", "count": 4}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "48/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "14", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.0% over one week, -1.9% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Molecular Partners AG (MOLN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution"}], "updated_at": "2026-06-22T15:06:11.054374+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}